These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
272 related articles for article (PubMed ID: 23436656)
1. The overexpression of hypomethylated miR-663 induces chemotherapy resistance in human breast cancer cells by targeting heparin sulfate proteoglycan 2 (HSPG2). Hu H; Li S; Cui X; Lv X; Jiao Y; Yu F; Yao H; Song E; Chen Y; Wang M; Lin L J Biol Chem; 2013 Apr; 288(16):10973-85. PubMed ID: 23436656 [TBL] [Abstract][Full Text] [Related]
2. Altered DNA methylation is associated with docetaxel resistance in human breast cancer cells. Kastl L; Brown I; Schofield AC Int J Oncol; 2010 May; 36(5):1235-41. PubMed ID: 20372798 [TBL] [Abstract][Full Text] [Related]
3. MiR-129-3p promotes docetaxel resistance of breast cancer cells via CP110 inhibition. Zhang Y; Wang Y; Wei Y; Li M; Yu S; Ye M; Zhang H; Chen S; Liu W; Zhang J Sci Rep; 2015 Oct; 5():15424. PubMed ID: 26487539 [TBL] [Abstract][Full Text] [Related]
4. miR-100 Reverses Cisplatin Resistance in Breast Cancer by Suppressing HAX-1. Wu G; Zhou W; Pan X; Sun Y; Xu H; Shi P; Li J; Gao L; Tian X Cell Physiol Biochem; 2018; 47(5):2077-2087. PubMed ID: 29975932 [TBL] [Abstract][Full Text] [Related]
5. miR-381 overcomes cisplatin resistance in breast cancer by targeting MDR1. Yi D; Xu L; Wang R; Lu X; Sang J Cell Biol Int; 2019 Jan; 43(1):12-21. PubMed ID: 30444043 [TBL] [Abstract][Full Text] [Related]
6. miR-141 confers docetaxel chemoresistance of breast cancer cells via regulation of EIF4E expression. Yao YS; Qiu WS; Yao RY; Zhang Q; Zhuang LK; Zhou F; Sun LB; Yue L Oncol Rep; 2015 May; 33(5):2504-12. PubMed ID: 25813250 [TBL] [Abstract][Full Text] [Related]
7. Decitabine (5-Aza-2'-deoxycytidine) decreased DNA methylation and expression of MDR-1 gene in K562/ADM cells. Ando T; Nishimura M; Oka Y Leukemia; 2000 Nov; 14(11):1915-20. PubMed ID: 11069027 [TBL] [Abstract][Full Text] [Related]
8. LncRNA XIST promotes chemoresistance of breast cancer cells to doxorubicin by sponging miR-200c-3p to upregulate ANLN. Zhang M; Wang F; Xiang Z; Huang T; Zhou WB Clin Exp Pharmacol Physiol; 2020 Aug; 47(8):1464-1472. PubMed ID: 32198770 [TBL] [Abstract][Full Text] [Related]
9. miRNA-34a is associated with docetaxel resistance in human breast cancer cells. Kastl L; Brown I; Schofield AC Breast Cancer Res Treat; 2012 Jan; 131(2):445-54. PubMed ID: 21399894 [TBL] [Abstract][Full Text] [Related]
10. MiR-139-5p inhibits the biological function of breast cancer cells by targeting Notch1 and mediates chemosensitivity to docetaxel. Zhang HD; Sun DW; Mao L; Zhang J; Jiang LH; Li J; Wu Y; Ji H; Chen W; Wang J; Ma R; Cao HX; Wu JZ; Tang JH Biochem Biophys Res Commun; 2015 Oct; 465(4):702-13. PubMed ID: 26299922 [TBL] [Abstract][Full Text] [Related]
11. A novel report of MiR-4301 induces cell apoptosis by negatively regulating DRD2 expression in human breast cancer cells. Gholipour N; Ohradanova-Repic A; Ahangari G J Cell Biochem; 2018 Aug; 119(8):6408-6417. PubMed ID: 29236292 [TBL] [Abstract][Full Text] [Related]
12. MicroRNA-3646 Contributes to Docetaxel Resistance in Human Breast Cancer Cells by GSK-3β/β-Catenin Signaling Pathway. Zhang X; Zhong S; Xu Y; Yu D; Ma T; Chen L; Zhao Y; Chen X; Yang S; Wu Y; Tang J; Zhao J PLoS One; 2016; 11(4):e0153194. PubMed ID: 27045586 [TBL] [Abstract][Full Text] [Related]
13. MiR-31 inhibits migration and invasion by targeting SATB2 in triple negative breast cancer. Luo LJ; Yang F; Ding JJ; Yan DL; Wang DD; Yang SJ; Ding L; Li J; Chen D; Ma R; Wu JZ; Tang JH Gene; 2016 Dec; 594(1):47-58. PubMed ID: 27593563 [TBL] [Abstract][Full Text] [Related]
14. Methylation of RASSF10 promotes cell proliferation and serves as a docetaxel resistant marker in human breast cancer. Dong T; Zhang M; Dong Y; Herman JG; van Engeland M; Zhong G; Guo M Discov Med; 2015 Nov; 20(111):261-71. PubMed ID: 26645898 [TBL] [Abstract][Full Text] [Related]
15. Methylation-regulated miR-149 modulates chemoresistance by targeting GlcNAc N-deacetylase/N-sulfotransferase-1 in human breast cancer. He DX; Gu XT; Li YR; Jiang L; Jin J; Ma X FEBS J; 2014 Oct; 281(20):4718-30. PubMed ID: 25156775 [TBL] [Abstract][Full Text] [Related]
16. MiR-222 and miR-29a contribute to the drug-resistance of breast cancer cells. Zhong S; Li W; Chen Z; Xu J; Zhao J Gene; 2013 Nov; 531(1):8-14. PubMed ID: 23994196 [TBL] [Abstract][Full Text] [Related]
17. MiR-346 promotes the biological function of breast cancer cells by targeting SRCIN1 and reduces chemosensitivity to docetaxel. Yang F; Luo LJ; Zhang L; Wang DD; Yang SJ; Ding L; Li J; Chen D; Ma R; Wu JZ; Tang JH Gene; 2017 Feb; 600():21-28. PubMed ID: 27913185 [TBL] [Abstract][Full Text] [Related]
18. Methylation-dependent silencing of the reduced folate carrier gene in inherently methotrexate-resistant human breast cancer cells. Worm J; Kirkin AF; Dzhandzhugazyan KN; Guldberg P J Biol Chem; 2001 Oct; 276(43):39990-40000. PubMed ID: 11509559 [TBL] [Abstract][Full Text] [Related]
19. MicroRNA-9 inhibition of cell proliferation and identification of novel miR-9 targets by transcriptome profiling in breast cancer cells. Selcuklu SD; Donoghue MT; Rehmet K; de Souza Gomes M; Fort A; Kovvuru P; Muniyappa MK; Kerin MJ; Enright AJ; Spillane C J Biol Chem; 2012 Aug; 287(35):29516-28. PubMed ID: 22761433 [TBL] [Abstract][Full Text] [Related]
20. Epigenetic regulation of miR-34b and miR-129 expression in gastric cancer. Tsai KW; Wu CW; Hu LY; Li SC; Liao YL; Lai CH; Kao HW; Fang WL; Huang KH; Chan WC; Lin WC Int J Cancer; 2011 Dec; 129(11):2600-10. PubMed ID: 21960261 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]